These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23962166)

  • 1. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
    Katas H; Abdul Ghafoor Raja M; Ee LC
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability.
    Hussain Z; Katas H; Yan SL; Jamaludin D
    Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of a new peptide vector for short interfering RNA delivery.
    Chen B; Xu W; Pan R; Chen P
    J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characterization of siRNA-peptide complexes.
    Law M; Jafari M; Chen P
    Biotechnol Prog; 2008; 24(4):957-63. PubMed ID: 19194904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
    Wan Y; Moyle PM; Gn PZ; Toth I
    Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
    Baoum A; Ovcharenko D; Berkland C
    Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.
    Malhotra M; Tomaro-Duchesneau C; Saha S; Kahouli I; Prakash S
    Int J Nanomedicine; 2013; 8():2041-52. PubMed ID: 23723699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
    Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
    Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
    Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
    J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-mimetic polymeric micelles for targeted siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2010 Aug; 31(22):5886-93. PubMed ID: 20427082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications.
    O'Mahony AM; Doyle D; Darcy R; Cryan JF; O'Driscoll CM
    Eur J Pharm Sci; 2012 Dec; 47(5):896-903. PubMed ID: 23022516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evaluation of a peptide-based siRNA delivery system in vitro.
    Chen B; Yoo K; Xu W; Pan R; Han XX; Chen P
    Drug Deliv Transl Res; 2017 Aug; 7(4):507-515. PubMed ID: 28349343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
    Kanazawa T; Morisaki K; Suzuki S; Takashima Y
    Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.
    Peng J; Rao Y; Yang X; Jia J; Wu Y; Lu J; Tao Y; Tu W
    Neurosci Lett; 2017 May; 650():153-160. PubMed ID: 28450191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
    Kang H; DeLong R; Fisher MH; Juliano RL
    Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
    Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
    J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.